Industry News
Studying How Elesclomol Works Reveals New Molecular Target For Melanoma Treatment
Aug 21, 2012
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood... Read More
Mouse Study Finds Clear Linkages Between Inflammation, Bacterial Communities And Cancer
Aug 21, 2012
What if a key factor ultimately behind a cancer was not a genetic defect but ecological? Ecologists have long known that when some major change disturbs an environment in some way, ecosystem structure is likely to change dramatically... Read More
Blood Markers Reveal Severity Of Common Kidney Disease
Aug 21, 2012
Increasing blood levels of particular proteins may act as warning signs for patients with one of the most common diseases of the kidney, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings could lead to better diagnosis and management of patients with the disease, called IgA nephropathy... Read More
Blood Markers Reveal Severity Of Common Kidney Disease
Aug 21, 2012
Increasing blood levels of particular proteins may act as warning signs for patients with one of the most common diseases of the kidney, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings could lead to better diagnosis and management of patients with the disease, called IgA nephropathy... Read More
Understanding The Link Between Indoor Tanning And Skin Cancer
Aug 20, 2012
In the United States, more than 3.5 million cases of skin cancer are diagnosed in more than 2 million people each year... Read More
Treatment For Cervical Disease Is Not Linked To Increased Risk Of Preterm Births
Aug 20, 2012
Treatment for cervical disease does not appear to increase the risk of subsequently giving birth prematurely, according to a study of over 44,000 women in England. The study, published online in the British Medical Journal recently, was the largest in the UK to investigate this and contradicts previous research suggesting treatment could be linked to an increased risk... Read More
Less Commonly Prescribed Antibiotic Cefazolin May Be Better Than Vancomycin For Treating Certain Bloodstream Infections
Aug 20, 2012
The antibiotic most commonly prescribed to treat bloodstream infections in dialysis patients may not always be the best choice, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). When Staphylococcus aureus bacteria gain access to a patient's bloodstream, the infection then becomes life threatening... Read More
B Cell Survival Holds Key To Chronic Graft Vs. Host Disease
Aug 20, 2012
Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival. In chronic Graft vs... Read More
B Cell Survival Holds Key To Chronic Graft Vs. Host Disease
Aug 20, 2012
Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their long-term survival. In chronic Graft vs... Read More
Genes Carried By E. coli Bacteria Linked To Colon Cancer
Aug 20, 2012
Scientists at the University of Liverpool have identified a type of E. coli bacteria that may encourage the development of colon cancer. The Liverpool team had previously shown that people with colon cancer and with the inflammatory bowel diseases, Crohn's disease and ulcerative colitis, have high numbers of a sticky type of E. coli in their colons. The team have now found that E... Read More
Previous Page Next Page